Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

£2m Deltex US, German growth:

This article was originally published in Clinica

Executive Summary

UK haemodynamic monitoring company Deltex Medical is looking to expand its sales and marketing operations in the US and Germany with £2m ($4m) of new capital it has secured. The funds, provided in the form of an equity investment-and-loan package, will come from US private equity firm Nexus Medical Partners, and its German affiliate Medicis Capital Partners. Deltex will use the financing to hire additional management and sales staff for its operations in US and Germany. The countries represent the two largest potential markets for the company's CardioQ monitor, according to Chichester, West Essex-based Deltex.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT046798

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel